Compare Prostate Cancer Treatments

Which Treatments Are Best in Keeping Men in Remission?

Here is your opportunity to compare prostate cancer treatments. Over 129,000 patients underwent PSA monitoring after treatment to see which treatments were most effective at keeping the cancer in remission. Graphs display PSA testing results after treatment to show which treatments are more likely to leave patients in remission, Prostate Cancer Free, for how many years. Share this data, talk with your Doctor, or multiple Doctors and make an informed decision. Select the treatment option, that is best for you.

Compare Prostate Cancer Treatments by gathering information about your own Prostate Cancer Diagnosis. Your Doctor will provide three elements that describe your prostate cancer. Your PSA, Stage and Gleason Score. These three elements help you determine your risk group. Find and select your Risk Group in the table below. This will take you to the comparing prostate cancer treatments page, where you can select different prostate cancer treatments on an interactive chart and graphically see their effectiveness over time.

The treatments included in this study are Prostate Surgery or Prostatectomy, (Retropubic, Laparoscopic, and Robotic), Brachytherapy or Seeds, High Dose Rate Radiation, HDR, External Beam Radiation Therapy or EBRT, Androgen Deprivation Therapy, ADT, or Hormone Treatment, Proton Therapy, High-Intensity Focused Ultrasound, HIFU, Cryotherapy, Cryo and Hypo-Fractionated External Beam Radiation Therapy. For more advanced prostate cancer, treatments are combined to increase effectiveness.

 

Compare Prostate Cancer Treatments

Treatment outcomes show how many patients remain prostate cancer free, and for how many years following treatment. These comparisons are done by patient Risk Group. Patients with prostate cancer that has been detected early, fall into the low risk group. Those with more advanced cancer will fall into intermediate or high risk groups of prostate cancer.

Compare Treatments by Selecting Your Risk Group

Low Risk

PSA less than 10
and
Gleason Score less than 7
and
Clinical Stage is T1c to T2a

Intermediate Risk

PSA greater than 10 less than 20
or
Gleason Score is 7
or
Clinical Stage is T2b

High Risk

PSA greater than 20
or
Gleason Score is 8 to 10
or
Clinical Stage is T2c to T3c

Prostate Cancer Free

Thirty Six Prostate Cancer Experts have analyzed the treatment outcomes of over 129,000 patients across the globe, following these patients for up to 15 years. The success of a treatment is determined by monitoring PSA for years after treatment. This data is presented to you, so you can see which treatments leave patients prostate cancer free. Watch this video to learn more.

Remission versus Recurrence?

Relapse of prostate cancer is way more common than you might think. Many men treated for prostate cancer have their cancer return, which can lead to a lifetime of treatment. Prostate Cancer Free studies treatment outcomes documented in "The STUDY", recently updated for 2021. Take this Study to your doctor, and discuss your chance of cancer recurrence. The Study is available with the new, just released booklet, to help you learn about prostate cancer. Both the Prostate Cancer Free Study and the booklet, “What You Need to Know About Prostate Cancer” are available NOW for you to VIEW, PRINT or DOWNLOAD.

Get The Study

Help To Continue the Work!

The Prostate Cancer Free Foundation, reviews the results of hundreds of thousands of men treated for prostate cancer. Tracking them for years. This information is available to you, and others like you, to help find the best prostate cancer treatment. This work takes time, effort, resources all of it done by volunteers. Please help us continue. Please Donate!